PULSE BIOSCIENCES, INC. — Director's Dealing 2017

May 13, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-05-12

Reporting Person: Thaure Thierry B. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-12	Common Stock	M	10000	$2.67	Acquired	10000	Direct
2017-05-12	Common Stock	S	5000	$23.90	Disposed	5000	Direct
2017-05-12	Common Stock	S	5000	$24.90	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-12	Stock Option (right to buy)	$2.67	M	10000	Disposed	2020-06-01	Common Stock (10000)	Direct

Footnotes

F1: The shares subject to the option will vest in equal quarterly installments over a three year period commencing on June 1, 2015 and ending on March 1, 2018, subject to the Reporting Person's continued service through each vesting date.